Abbott Facing Stent Injunction After French Ruling

Law360, New York (January 5, 2007, 12:00 AM EST) -- Drug maker Abbott Laboratories Inc. has been dealt a blow in a patent dispute after a French court ruled a Canadian rival could stop the company from selling a medical device it recently bought from Guidant Corp.

The ruling, handed down by the Tribunal de Grande Instance de Paris, allows privately held Evysio Medical Devices ULC to enjoin Abbott from selling a drug-eluting coronary stent in France sold under the name Xience V.

Evysio is working in legal tandem with Minneapolis-based medical device firm Medtronic Inc.,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.